ProfileGDS5678 / 1435853_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 41% 41% 41% 41% 42% 46% 41% 41% 41% 43% 41% 43% 41% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0228542
GSM967853U87-EV human glioblastoma xenograft - Control 22.9480141
GSM967854U87-EV human glioblastoma xenograft - Control 32.9521341
GSM967855U87-EV human glioblastoma xenograft - Control 42.8857441
GSM967856U87-EV human glioblastoma xenograft - Control 52.8912141
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0712342
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1416646
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9254341
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9142241
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9337341
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9925743
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9051641
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9938943
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9456641